The Company Yumanity Therapeutics Inc. (United States), is listed on Nasdaq with a market value of $ 18.67 Millions, having an equity of $ 5.48 Millions.
With a total of 46 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.
In the last 12 months the Company had a revenue of $ 1.10 Million, which generated a loss in the amount of $ -32.00 Millions.
As for its main indicators, the Company has a P/E ratio of -0.58, a P/BV ratio of 3.41 and in the last 12 months the Company did not pay dividends.
The Company is traded internationally through the ticker YMTX.